Effects of tibolone on the quality of life, anxiety‐depression levels and cognitive functions in natural menopause: An observational follow‐up study
- 24 February 2005
- journal article
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 45 (1), 71-73
- https://doi.org/10.1111/j.1479-828x.2005.00345.x
Abstract
The effects of tibolone on the quality of life (QoL), depression-anxiety levels and cognitive functions were investigated. Seventeen women received tibolone and 25 women did not receive any medication. At the end of the 6-month follow-up period, the QoL was better in the tibolone group in the area of mental health. Disability, anxiety symptoms, menopausal symptoms were significantly reduced in this group.Keywords
This publication has 5 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Quality of life and sexuality changes in postmenopausal women receiving tibolone therapyClimacteric, 2001
- Current perspectives on benefits and risks of hormone replacement therapyAmerican Journal of Obstetrics and Gynecology, 2001
- Quality of life and sexuality changes in postmenopausal women receiving tibolone therapyClimacteric, 2001
- A new methodological approach to the evaluation of quality of life in postmenopausal womenMaturitas, 1992